Maviret (glecaprevir/pibrentasvir)

Block 1

Maviret (glecaprevir/pibrentasvir) Wholesaler

Maviret (glecaprevir/pibrentasvir) wholesaler, supplier

MAVIRET (GLECAPREVIR/PIBRENTASVIR) DESCRIPTION:

Maviret is a combination of the following two DAAs:

  • glecaprevir – a protease inhibitor that works by interfering with a protein needed by the virus
  • pibrentasvir – an NS5A (hepatitis C virus non-structural protein 5A) inhibitor that interferes with the production of the pieces needed to build new virus particles

Together, these two drugs greatly reduce and then stop the production of new copies of HCV.

MAVIRET (GLECAPREVIR/PIBRENTASVIR) INDICATIONS:

Maviret is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and in adolescents aged 12 to <18 years 

DOSAGE FORM & STRENGTH:

  • Maviret 100mg/40mg (glecaprevir/pibrentasvir) wholesaler

Rasso Swiss Pharma is a Wholesaler, supplier and distributor for Maviret 100mg/40mg (glecaprevir/pibrentasvir).

<< Back to products